Published in J Control Release on July 20, 2005
Comparison of release-controlling efficiency of polymeric coating materials using matrix-type casted films and diffusion-controlled coated tablet. AAPS PharmSciTech (2010) 0.79
A new application of lipid nanoemulsions as coating agent, providing zero-order hydrophilic drug release from tablets. J Drug Deliv (2012) 0.75
Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability. AAPS PharmSciTech (2014) 0.75
Interpolyelectrolyte complexes of Eudragit® EPO with hypromellose acetate succinate and Eudragit® EPO with hypromellose phthalate as potential carriers for oral controlled drug delivery. AAPS PharmSciTech (2015) 0.75
Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine. PLoS One (2016) 0.75
Effects of plasticizers and surfactants on the film forming properties of hydroxypropyl methylcellulose for the coating of diclofenac sodium tablets. Saudi Pharm J (2009) 0.75
TOPS: an internet-based system to prevent healthy subjects from over-volunteering for clinical trials. Eur J Clin Pharmacol (2012) 2.80
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat (1998) 2.64
Xanthogranulomatous cystitis. J Urol (1985) 1.89
Do patients with congenital hemiparesis and ipsilateral corticospinal projections respond differently to constraint-induced movement therapy? Dev Med Child Neurol (2008) 1.81
Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res (1998) 1.66
Effect of ion exchange resins on the drug release from matrix tablets. Eur J Pharm Biopharm (1998) 1.54
Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur J Pharm Sci (2003) 1.44
Transient bone marrow oedema of the foot. Int Orthop (2001) 1.41
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers. Vaccine (2006) 1.39
Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. Surgery (1998) 1.38
Far-infrared vibrational modes of DNA components studied by terahertz time-domain spectroscopy. Phys Med Biol (2002) 1.37
pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. J Control Release (2000) 1.36
Pulsatile drug-delivery systems. Crit Rev Ther Drug Carrier Syst (2001) 1.34
HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics. Pharm Res (1999) 1.32
Floating microparticles based on low density foam powder. Int J Pharm (2002) 1.32
Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. J Microencapsul (1990) 1.30
PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur J Pharm Sci (2002) 1.29
How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int J Pharm (2006) 1.24
The role of vesicostomy in the management of anterior urethral valves in neonates and infants. J Urol (1987) 1.22
Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles. J Microencapsul (2003) 1.18
Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states. J Pharm Sci (2000) 1.18
Balance sheets of knee and functional scores 5 years after total knee arthroplasty for osteoarthritis: a source for patient information. J Arthroplasty (2000) 1.16
Conversion of cucumber linoleate 13-lipoxygenase to a 9-lipoxygenating species by site-directed mutagenesis. Proc Natl Acad Sci U S A (1999) 1.16
PLGA-based drug delivery systems: importance of the type of drug and device geometry. Int J Pharm (2007) 1.13
Floating or pulsatile drug delivery systems based on coated effervescent cores. Int J Pharm (1999) 1.11
Tackiness of acrylic and cellulosic polymer films used in the coating of solid dosage forms. Eur J Pharm Biopharm (1999) 1.10
Polymer blends for controlled release coatings. J Control Release (2007) 1.07
Diffusion-controlled drug delivery systems: calculation of the required composition to achieve desired release profiles. J Control Release (1999) 1.06
How to adjust desired drug release patterns from ethylcellulose-coated dosage forms. J Control Release (2007) 1.06
Drugs acting as plasticizers in polymeric systems: a quantitative treatment. J Control Release (2006) 1.04
Swelling of and drug release from monoglyceride-based drug delivery systems. J Pharm Sci (1997) 1.03
Spectral collapse in ensembles of metamolecules. Phys Rev Lett (2010) 0.99
Cortical neuromodulation by constraint-induced movement therapy in congenital hemiparesis: an FMRI study. Neuropediatrics (2007) 0.99
Protection of moisture-sensitive drugs with aqueous polymer coatings: importance of coating and curing conditions. Int J Pharm (2009) 0.99
Compression of pellets coated with various aqueous polymer dispersions. Int J Pharm (2004) 0.99
Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods. Eur J Pharm Biopharm (1998) 0.98
Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus. Hum Genet (1991) 0.98
Reliability of the novel 7-joint ultrasound score: results from an inter- and intraobserver study performed by rheumatologists. Arthritis Care Res (Hoboken) (2012) 0.97
Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder. J Control Release (1999) 0.97
Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory. Int J Pharm (2006) 0.95
Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres. J Control Release (2000) 0.95
Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles. Eur J Pharm Sci (2008) 0.94
Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur J Pharm Biopharm (2003) 0.92
Drug release from MCC- and carrageenan-based pellets: experiment and theory. Eur J Pharm Biopharm (2009) 0.92
Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles. Int J Pharm (2005) 0.92
Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer. Clin Cancer Res (1995) 0.92
Taenia saginata cysticercosis: a comparison of routine meat inspection and carcase dissection results in calves. Vet Rec (1981) 0.92
Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design. J Control Release (2000) 0.91
What does it take to control malaria? Ann Trop Med Parasitol (2007) 0.91
Survey of users of TOPS, an internet-based system to prevent healthy subjects from over-volunteering for clinical trials. Eur J Clin Pharmacol (2013) 0.91
Melt extrusion--an alternative method for enhancing the dissolution rate of 17beta-estradiol hemihydrate. Eur J Pharm Biopharm (2000) 0.90
Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease. Genes Chromosomes Cancer (2001) 0.90
Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer. J Control Release (2004) 0.90
A pulsatile drug delivery system based on rupturable coated hard gelatin capsules. J Control Release (2003) 0.90
Injectability of biodegradable in situ forming microparticle systems (ISM). Eur J Pharm Sci (2008) 0.89
Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems. Int J Pharm (2001) 0.89
Ethanol-resistant polymeric film coatings for controlled drug delivery. J Control Release (2013) 0.89
Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems. J Control Release (2006) 0.88
Structural basis for lipoxygenase specificity. Conversion of the human leukocyte 5-lipoxygenase to a 15-lipoxygenating enzyme species by site-directed mutagenesis. J Biol Chem (2001) 0.88
Curing of aqueous polymeric film coatings: Importance of the coating level and type of plasticizer. Eur J Pharm Biopharm (2009) 0.88
Transient marrow edema syndrome of the hip: results after core decompression. A prospective MRI-controlled study in 22 patients. Arch Orthop Trauma Surg (2003) 0.88
Modeling drug release from PVAc/PVP matrix tablets. J Control Release (2009) 0.87
Incorporation of polymeric nanoparticles into solid dosage forms. J Control Release (1999) 0.87
Blends of enteric and GIT-insoluble polymers used for film coating: physicochemical characterization and drug release patterns. J Control Release (2003) 0.87
Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio. Int J Pharm (2009) 0.86
Characterisation of quaternary polymethacrylate films containing tartaric acid, metoprolol free base or metoprolol tartrate. Eur J Pharm Biopharm (2009) 0.86
In vitro and in vivo evaluation of carbamazepine-loaded enteric microparticles. Int J Pharm (2006) 0.86
pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP. Eur J Pharm Biopharm (2004) 0.86
Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J Pharm Pharmacol (2000) 0.86
Deeper insight into the drug release mechanisms in Eudragit RL-based delivery systems. Int J Pharm (2010) 0.86
Pharmaceutical applications of shellac: moisture-protective and taste-masking coatings and extended-release matrix tablets. Drug Dev Ind Pharm (2003) 0.86
Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling. J Control Release (2003) 0.86
Low level of intracortical inhibition in children shown by transcranial magnetic stimulation. Neuropediatrics (2004) 0.85
Application of terahertz pulsed imaging to analyse film coating characteristics of sustained-release coated pellets. Int J Pharm (2013) 0.85
A novel in situ forming drug delivery system for controlled parenteral drug delivery. Int J Pharm (2006) 0.85
Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles. Int J Pharm (2003) 0.85
Controlled drug release from Gelucire-based matrix pellets: experiment and theory. Int J Pharm (2006) 0.84
The efficacy of praziquantel against Taenia saginata cysticercosis in naturally infected calves. Tropenmed Parasitol (1979) 0.84
The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J Control Release (2000) 0.84
Condylomata acuminata and verrucous carcinoma of the bladder: case report and literature review. J Urol (1986) 0.84